Historial del iniciado
OtroTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
No hay puntuaciones de señal disponibles.
Browse the full record of transactions filed by Rodriguez Javier. Insider active across 1 company, notably BioXcel Therapeutics, Inc.. In total, 21 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €6k. History available since 20 May 2026. The latest transaction was disclosed on 20 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rodriguez Javier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones21 en total
35 títulosCommon StockSEC:0001104659-26-075302:0
6560 títulos@ 1,084 US$0.020% mcap100.0% de su flujoCommon StockSEC:0001104659-26-065839:1
17.500 títulosCommon StockSEC:0001104659-26-065839:0
33 títulosCommon StockSEC:0001104659-26-028720:0
33 títulosCommon StockSEC:0001104659-25-121302:0
33 títulosCommon StockSEC:0001104659-25-090516:0
35 títulosCommon StockSEC:0001104659-25-090516:1
4375 títulosCommon StockSEC:0001104659-25-069700:0
625 títulosCommon StockSEC:0001104659-25-069700:1
33 títulosCommon StockSEC:0001104659-25-059979:0
31 títulosCommon StockSEC:0001104659-25-024533:0
521 títulosCommon StockSEC:0001104659-24-129458:0
21.250 títulosCommon StockSEC:0001104659-24-106063:0
521 títulosCommon StockSEC:0001104659-24-100748:0
521 títulosCommon StockSEC:0001104659-24-073001:0
521 títulosCommon StockSEC:0001104659-24-044858:0
521 títulosCommon StockSEC:0001104659-23-126923:0
521 títulosCommon StockSEC:0001104659-23-101639:0
521 títulosCommon StockSEC:0001104659-23-072399:0
5000 títulosCommon StockSEC:0001104659-23-061537:0
2084 títulosCommon StockSEC:0001104659-23-033400:0
About Rodriguez Javier
Rodriguez Javier is a declarant linked to BioXcel Therapeutics, Inc. (XNAS), with 21 filings in total. Across the 21 most recent sampled filings, the period runs from 2023-03-16 to 2026-06-17, with sales of EUR 6117 and the most frequent transaction nature listed as option exercise.